Could erectile dysfunction be a marker of atherosclerotic cardiovascular disease?
The paper is focused on erectile dysfunction (ED) as an inter-disciplinary problem. The detailed analysis of relevant clinical trials and meta-analyses is performed, demonstrating a causal relationship between ED and coronary heart disease, arterial hypertension, dyslipidemias, and diabetes mellitus...
Saved in:
Main Authors: | G. G. Sharvadze, M. N. Mamedov, E. A. Poddubskaya, D. G. Kurbatov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2166 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
by: M. N. Mamedov, et al.
Published: (2016-01-01) -
Algorithm of diagnostics of erectile dysfunction in patients with arterial hypertension and dynamics of arterial blood pressure against the background of androgenic deficiency
by: O.R. Vintoniv, et al.
Published: (2021-06-01) -
RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES
by: E. V. Minakov, et al.
Published: (2016-01-01) -
Erectile dysfunction and cardiovascular disease: old problem, new approaches
by: S. I. Gamidov, et al.
Published: (2006-12-01) -
MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS
by: G. G. Sharvadze, et al.
Published: (2018-06-01)